Adagene (ADAG) Retained Earnings (2019 - 2025)
Adagene's (ADAG) quarterly Retained Earnings came in at $366043.5 billion in Q4 2025, up 1.06% year-on-year from $362220.4 billion in Q4 2024, and up 100491088.46% on a QoQ basis from $364.3 million in Q2 2025.
Adagene (ADAG) Retained Earnings (2019 - 2025) Analysis & Trends
Adagene (ADAG) has 7 years of Retained Earnings data on file, last reported at $366043.5 billion in Q4 2025.
- On a quarterly basis, Retained Earnings rose 1.06% year-over-year to $366043.5 billion in Q4 2025; TTM through Dec 2025 was $366043.5 billion, a 1.06% increase from a year earlier, with the FY2025 full-year figure at $366043.5 billion, up 1.06% from the prior year.
- Retained Earnings for Q4 2025 stood at $366043.5 billion, up from $364.3 million in the prior quarter.
- Over the last five years, Retained Earnings for ADAG reached as high as $366043.5 billion in Q4 2025 and fell as low as -$93981.0 in Q4 2021.
- Historically, Retained Earnings has averaged $211070.0 billion across 5 years, with a median of $342685.3 billion in 2022.
- Across the five-year window, Retained Earnings soared 364689956580.57% in 2022 and sank 100.0% in 2024, its largest moves.
- Year by year, Retained Earnings stood at -$93981.0 in 2021, then surged by 364689956580.57% to $342739.3 billion in 2022, then grew by 2.15% to $350105.5 billion in 2023, then grew by 3.46% to $362220.4 billion in 2024, then increased by 1.06% to $366043.5 billion in 2025.
- Per Business Quant data, the three most recent Retained Earnings figures were $366043.5 billion in Q4 2025, $364.3 million in Q2 2025, and $362220.4 billion in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Adagene | 198.85 Mn | 198.85 Mn | - | 366,043.46 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 366,043.46 Bn |
| Jun 30, 2025 | 364.25 Mn |
| Dec 31, 2024 | 362,220.45 Bn |
| Jun 30, 2024 | 352.65 Mn |
| Dec 31, 2023 | 350,105.52 Bn |
| Jun 30, 2023 | 346,958.52 Bn |
| Dec 31, 2022 | 342,739.27 Bn |
| Jun 30, 2022 | 342,631.31 Bn |
| Dec 31, 2021 | -93,981.00 |
| Jun 30, 2021 | 329.22 Mn |
| Dec 31, 2020 | -105.66 Mn |
| Dec 31, 2019 | -63.26 Mn |